Study reveals 15 hidden genetic risk factors for celiac disease
View as a Web Page
News Medical
 
  Hematology Hematology logo  
  The latest hematology news from News Medical  
 Nanoplastics reshape gut microbiome, weakening gut defensesNanoplastics reshape gut microbiome, weakening gut defenses
 
Polystyrene nanoplastics impact gut health by modifying microbiota interactions via extracellular vesicles, raising concerns about environmental nanoplastics.
 
 
 Study reveals 15 hidden genetic risk factors for celiac diseaseStudy reveals 15 hidden genetic risk factors for celiac disease
 
This comprehensive GWAS reveals 15 new genetic variants linked to celiac disease, offering insights for earlier detection and tailored treatment strategies.
 
   New data reveals insights into cancer and cardiovascular safety of JAK inhibitorsNew data reveals insights into cancer and cardiovascular safety of JAK inhibitors
 
Now, the work presented at the 2025 annual EULAR congress in Barcelona adds two important pieces to the puzzle.
 
   Maternal iron deficiency disrupts embryonic sex determination in miceMaternal iron deficiency disrupts embryonic sex determination in mice
 
Developmentally expressed genes play a fundamental role in the formation of a wide range of organs. The Y chromosome-located mammalian sex-determining gene Sry, required for the formation of testis, is activated only within a narrow time window during embryogenesis.
 
   Breakthrough soft robotics could redefine artificial heart technologyBreakthrough soft robotics could redefine artificial heart technology
 
The Hybrid Heart, a soft robotic total artificial heart, offers a breakthrough in treating end-stage heart failure with improved biocompatibility and function.
 
 New cancer vaccine shows promise against deadly pancreatic tumors
 
New cancer vaccine shows promise against deadly pancreatic tumorsPancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society.
 
 
 Rapid generation of functional blood vessels from human stem cells
 
Rapid generation of functional blood vessels from human stem cellsBlood vessels are essential to nearly all tissues, delivering nutrients and oxygen, regulating hemostasis, and modulating inflammation.
 
 
 New switchable CAR-T therapy enters phase 1 trial for advanced breast cancer
 
New switchable CAR-T therapy enters phase 1 trial for advanced breast cancerThe Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a milestone in cancer treatment with the dosing of the first patient in a phase 1 trial (NCT06878248) evaluating CLBR001 + ABBV-461, a modular, switchable chimeric antigen receptor T cell (sCAR-T) therapy in patients with advanced or metastatic breast cancer who have no suitable treatment options.
 
 
 Deep B cell depletion offers new hope for rheumatologic and musculoskeletal diseases
 
CD19-CAR T-cell treatment is a novel option of deep B cell depletion with promising results across different rheumatologic and musculoskeletal diseases (RMD).
 
 
 Genetic mutation tied to Crohn's disease can worsen iron deficiency and anemia
 
Genetic mutation tied to Crohn's disease can worsen iron deficiency and anemiaA study led by biomedical scientists at the University of California, Riverside School of Medicine shows how a genetic mutation associated with Crohn's disease can worsen iron deficiency and anemia - one of the most common complications experienced by patients with inflammatory bowel disease, or IBD.
 
 
 New drug combination shows high remission rates in acute myeloid leukemia
 
New drug combination shows high remission rates in acute myeloid leukemiaA combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia (AML) showed high rates of complete remission in an early-phase clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and 11 other sites nationwide.
 
 
 Gene therapy shows long-term success in hemophilia B patients
 
Gene therapy shows long-term success in hemophilia B patientsA gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's Research Hospital and University College London today report thirteen years of follow-up data.
 
 
 Early clinical events predict disease progression in very early systemic sclerosis
 
Early clinical events predict disease progression in very early systemic sclerosisThe VEDOSS project has previously shown that 70% of patients with Raynaud's phenomenon and at least one red flag – systemic sclerosis (SSc)-specific antibodies, puffy fingers, or an SSc pattern on nailfold capillaroscopy –will fulfil the 2013 ACR/EULAR SSc criteria within 5 years.
 
 
 Breakthrough tumor profiling study offers hope for more precise skin cancer care
 
Breakthrough tumor profiling study offers hope for more precise skin cancer careEvery tumor is unique. This makes it difficult to find the most effective therapy for treatment. The Tumor Profiler Center of the University Hospital Zurich, the University of Zurich, ETH Zurich and the University Hospital Basel has now carried out a study in which nine different molecular biological technologies were used to precisely measure the properties of the tumor in four weeks and enable a precise treatment decision.
 
 
 Predicting deep vein thrombosis in patients with epithelial ovarian cancer using a nomogram
 
Predicting deep vein thrombosis in patients with epithelial ovarian cancer using a nomogramNomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide personalized treatment to formulate preventive measures for various diseases.
 
 
 CHAF1B drives lung squamous cell carcinoma progression by repressing SETD7
 
CHAF1B drives lung squamous cell carcinoma progression by repressing SETD7CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and linked to tumor progression, but its role in lung squamous-cell carcinoma (LUSC) remained unclear.
 
 
 SIRT6 identified as a critical safeguard of spinal disc health
 
SIRT6  identified as a critical safeguard of spinal disc healthLow back pain is the most prevalent musculoskeletal condition worldwide and is closely tied to the progressive degeneration of intervertebral discs.
 
 
 Biweekly chemotherapy dosing reduces toxicity in colorectal cancer patients
 
Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw similar treatment effectiveness and reduced toxicity compared with treatment using standard dosing schedules, according to a recent study in The Oncologist that was co-authored by a Fox Chase Cancer Center physician.
 
 
 PDE3 inhibitors show promise in promoting bone growth
 
PDE3 inhibitors show promise in promoting bone growthBone growth occurs through the proliferation of specialized cells of the cartilage tissue, known as chondrocytes, on either end of a bone.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025